|
1
|
Brouquet A and Nordlinger B: Metastatic
colorectal cancer outcome and fatty liver disease. Nat Rev
Gastroenterol Hepatol. 10:266–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuipers EJ, Rösch T and Bretthauer M:
Colorectal cancer screening - optimizing current strategies and new
directions. Nat Rev Clin Oncol. 10:130–142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schmoll HJ and Stein A: Colorectal cancer
in 2013: Towards improved drugs, combinations and patient
selection. Nat Rev Clin Oncol. 11:79–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanko Y, Mohammed A, Okasha MA, Umar AH
and Magaji RA: Anti-nociceptive and anti-inflammatory activities of
ethanol extract of Syzygium aromaticum flower bud in Wistar rats
and mice. Afr J Tradit Complement Altern Med. 5:209–212.
2008.PubMed/NCBI
|
|
6
|
Han X and Parker TL: Anti-inflammatory
activity of clove (Eugenia caryophyllata) essential oil in human
dermal fibroblasts. Pharm Biol. 55:1619–1622. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aboubakr HA, Nauertz A, Luong NT, Agrawal
S, El-Sohaimy SA, Youssef MM and Goyal SM: In vitro antiviral
activity of clove and ginger aqueous extracts against Feline
calicivirus, a surrogate for human norovirus. J Food Prot.
79:1001–1012. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abd El Azim MHM, El-Mesallamy AMD,
El-Gerby M and Awad A: Anti-tumor, antioxidant and antimicrobial
and the phenolic constituents of clove flower Buds
(Syzygiumaromaticum). J Microb Biochem Technol. 10:s8–s007.
2014.
|
|
9
|
Gülçin I, Şat G, Beydemir S, Elmastaş M
and Küfrevioǧlu I: Comparison of antioxidant activity of clove
(Eugenia caryophylata Thunb.) buds and lavender (Lavandulastoechas
L.). Food Chem. 87:393–400. 2004. View Article : Google Scholar
|
|
10
|
Banerjee S, Panda CK and Das S: Clove
(Syzygium aromaticum L.), a potential chemopreventive agent for
lung cancer. Carcinogenesis. 27:1645–1654. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kubatka P, Uramova S, Kello M, Kajo K,
Kruzliak P, Mojzis J, Vybohova D, Adamkov M, Jasek K, Lasabova Z,
et al: Antineoplastic effects of clove buds (Syzygium aromaticum
L.) in the model of breast carcinoma. J Cell Mol Med. 21:2837–2851.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Schmitz JC, Wei J, Cao S, Beumer
JH, Strychor S, Cheng L, Liu M, Wang C, Wu N, et al: Clove extract
inhibits tumor growth and promotes cell cycle arrest and apoptosis.
Oncol Res. 21:247–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei J, Liu M, Liu H, Wang H, Wang F, Zhang
Y, Han L and Lin X: Oleanolic acid arrests cell cycle and induces
apoptosis via ROS-mediated mitochondrial depolarization and
lysosomal membrane permeabilization in human pancreatic cancer
cells. J Appl Toxicol. 33:756–765. 2013. View Article : Google Scholar
|
|
14
|
Ameisen JC: On the origin, evolution, and
nature of programmed cell death: A timeline of four billion years.
Cell Death Differ. 9:367–393. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gerl R and Vaux DL: Apoptosis in the
development and treatment of cancer. Carcinogenesis. 26:263–270.
2005. View Article : Google Scholar
|
|
16
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Putcha GV, Harris CA, Moulder KL, Easton
RM, Thompson CB and Johnson EM Jr: Intrinsic and extrinsic pathway
signaling during neuronal apoptosis: Lessons from the analysis of
mutant mice. J Cell Biol. 157:441–453. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar
|
|
19
|
Apel A, Zentgraf H, Büchler MW and Herr I:
Autophagy-A double-edged sword in oncology. Int J Cancer.
125:991–995. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Zhang Y, Qu J, Xu L, Hou K, Zhang
J, Qu X and Liu Y: β-Elemene-induced autophagy protects human
gastric cancer cells from undergoing apoptosis. BMC Cancer.
11:1832011. View Article : Google Scholar
|
|
21
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kimmelman AC and White E: Autophagy and
tumor metabolism. Cell Metab. 25:1037–1043. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zarzynska JM: The importance of autophagy
regulation in breast cancer development and treatment. BioMed Res
Int. 2014:7103452014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li JP, Yang YX, Liu QL, Pan ST, He ZX,
Zhang X, Yang T, Chen XW, Wang D, Qiu JX, et al: The
investigational Aurora kinase A inhibitor alisertib (MLN8237)
induces cell cycle G2/M arrest, apoptosis, and autophagy via p38
MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Drug Des Devel Ther. 9:1627–1652. 2015.PubMed/NCBI
|
|
25
|
Nagelkerke A, Bussink J, Geurts-Moespot A,
Sweep FC and Span PN: Therapeutic targeting of autophagy in cancer.
Part II: Pharmacological modulation of treatment-induced autophagy.
Semin Cancer Biol. 31:99–105. 2015. View Article : Google Scholar
|
|
26
|
Shimizu T, Tolcher AW, Papadopoulos KP,
Beeram M, Rasco DW, Smith LS, Gunn S, Smetzer L, Mays TA, Kaiser B,
et al: The clinical effect of the dual-targeting strategy involving
PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced
cancer. Clin Cancer Res. 18:2316–2325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Porta C, Paglino C and Mosca A: Targeting
PI3K/Akt/mTOR signaling in cancer. Front Oncol. 4:642014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhirnov OP and Klenk HD: Control of
apoptosis in influenza virus-infected cells by up-regulation of Akt
and p53 signaling. Apoptosis. 12:1419–1432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Roper J, Richardson MP, Wang WV, Richard
LG, Chen W, Coffee EM, Sinnamon MJ, Lee L, Chen PC, Bronson RT, et
al: The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor
regression in a genetically engineered mouse model of PIK3CA
wild-type colorectal cancer. PLoS One. 6:e251322011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu J, Zheng L, Zhong J, Wu N, Liu G and
Lin X: Oleanolic acid induces protective autophagy in cancer cells
through the JNK and mTOR pathways. Oncol Rep. 32:567–572. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang S, Zhao Q, Xiang H, Liu M, Zhang Q,
Xue W, Song B and Yang S: Antiproliferative activity and
apoptosis-inducing mechanism of constituents from Toona sinensis on
human cancer cells. Cancer Cell Int. 13:122013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wlodkowic D, Telford W, Skommer J and
Darzynkiewicz Z: Apoptosis and beyond: Cytometry in studies of
programmed cell death. Methods Cell Biol. 103:55–98. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Acevedo Arozena A, et al: Guidelines for the use
and interpretation of assays for monitoring autophagy (3rd
edition). Autophagy. 12:1–222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu ZX, Liang J, Haridas V, Gaikwad A,
Connolly FP, Mills GB and Gutterman JU: A plant triterpenoid,
avicin D, induces autophagy by activation of AMP-activated protein
kinase. Cell Death Differ. 14:1948–1957. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu YT, Tan HL, Shui G, Bauvy C, Huang Q,
Wenk MR, Ong CN, Codogno P and Shen HM: Dual role of
3-methyladenine in modulation of autophagy via different temporal
patterns of inhibition on class I and III phosphoinositide
3-kinase. J Biol Chem. 285:10850–10861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Klionsky DJ, Baehrecke EH, Brumell JH, Chu
CT, Codogno P, Cuervo AM, et al: A comprehensive glossary of
autophagy-related molecules and processes (2nd edition). Autophagy.
7:1273–1294. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Periyasamy-Thandavan S, Jiang M, Wei Q,
Smith R, Yin XM and Dong Z: Autophagy is cytoprotective during
cisplatin injury of renal proximal tubular cells. Kidney Int.
74:631–640. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shao X, Lai D, Zhang L and Xu H: Induction
of autophagy and apoptosis via PI3K/AKT/TOR pathways by
azadirachtin A in spodopteralitura cells. Sci Rep. 6:54822016.
View Article : Google Scholar
|
|
40
|
Cheng Y, Diao D, Zhang H, Guo Q, Wu X,
Song Y and Dang C: High glucose-induced resistance to
5-fluorouracil in pancreatic cancer cells alleviated by
2-deoxy-D-glucose. Biomed Rep. 2:188–192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Povsic TJ, Kohout TA and Lefkowitz RJ:
β-arrestin1 mediates insulin-like growth factor 1 (IGF-1)
activation of phosphati-dylinositol 3-kinase (PI3K) and
anti-apoptosis. J Biol Chem. 278:51334–51339. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li H, He N, Li X, Zhou L, Zhao M, Jiang H
and Zhang X: Oleanolic acid inhibits proliferation and induces
apoptosis in NB4 cells by targeting PML/RARα. Oncol Lett.
6:885–890. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shanmugam MK, Dai X, Kumar AP, Tan BK,
Sethi G and Bishayee A: Oleanolic acid and its synthetic
derivatives for the prevention and therapy of cancer: Preclinical
and clinical evidence. Cancer Lett. 346:206–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ghosh R, Nadiminty N, Fitzpatrick JE,
Alworth WL, Slaga TJ and Kumar AP: Eugenol causes melanoma growth
suppression through inhibition of E2F1 transcriptional activity. J
Biol Chem. 280:5812–5819. 2005. View Article : Google Scholar
|
|
45
|
Slamenová D, Horváthová E, Wsólová L,
Sramková M and Navarová J: Investigation of anti-oxidative,
cytotoxic, DNA-damaging and DNA-protective effects of plant
volatiles eugenol and borneol in human-derived HepG2, Caco-2 and
VH10 cell lines. Mutat Res. 677:46–52. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Al-Sharif I, Remmal A and Aboussekhra A:
Eugenol triggers apoptosis in breast cancer cells through
E2F1/survivin down-regulation. BMC Cancer. 13:6002013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yi JL, Shi S, Shen YL, Wang L, Chen HY,
Zhu J and Ding Y: Myricetin and methyl eugenol combination enhances
the anticancer activity, cell cycle arrest and apoptosis induction
of cis-platin against HeLa cervical cancer cell lines. Int J Clin
Exp Pathol. 8:1116–1127. 2015.PubMed/NCBI
|
|
48
|
Pourgholami MH, Kamalinejad M, Javadi M,
Majzoob S and Sayyah M: Evaluation of the anticonvulsant activity
of the essential oil of Eugenia caryophyllata in male mice. J
Ethnopharmacol. 64:167–171. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Amaravadi RK, Yu D, Lum JJ, Bui T,
Christophorou MA, Evan GI, Thomas-Tikhonenko A and Thompson CB:
Autophagy inhibition enhances therapy-induced apoptosis in a
Myc-induced model of lymphoma. J Clin Invest. 117:326–336. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chresta CM, Davies BR, Hickson I, Harding
T, Cosulich S, Critchlow SE, Vincent JP, Ellston R, Jones D, Sini
P, et al: AZD8055 is a potent, selective, and orally bioavailable
ATP-competitive mammalian target of rapamycin kinase inhibitor with
in vitro and in vivo antitumor activity. Cancer Res. 70:288–298.
2010. View Article : Google Scholar
|
|
51
|
Li X and Fan Z: The epidermal growth
factor receptor antibody cetuximab induces autophagy in cancer
cells by downregulating HIF-1alpha and Bcl-2 and activating the
beclin 1/hVps34 complex. Cancer Res. 70:5942–5952. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sasaki K, Tsuno NH, Sunami E, Tsurita G,
Kawai K, Okaji Y, Nishikawa T, Shuno Y, Hongo K, Hiyoshi M, et al:
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on
colon cancer cells. BMC Cancer. 10:3702010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen X, Yuan LQ, Li LJ, Lv Y, Chen PF and
Pan L: Suppression of gastric cancer by extract from the tuber of
amorphophallus konjac via induction of apoptosis and autophagy.
Oncol Rep. 38:1051–1058. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Al-Daghri NM, Alokail MS, Alkharfy KM,
Mohammed AK, Abd-Alrahman SH, Yakout SM, Amer OE and Krishnaswamy
S: Fenugreek extract as an inducer of cellular death via autophagy
in human T lymphoma Jurkat cells. BMC Complement Altern Med.
12:2022012. View Article : Google Scholar : PubMed/NCBI
|
